Is HSDB 8173 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HSDB 8173? Is HSDB 8173 safe for nursing mother and child? Does HSDB 8173 extracts into breast milk? Does HSDB 8173 has any long term or short term side effects on infants? Can HSDB 8173 influence milk supply or can HSDB 8173 decrease milk supply in lactating mothers?
Answer by DrLact: About HSDB 8173 usage in lactation
No information is available on the clinical use of HSDB 8173 during breastfeeding. Because HSDB 8173 is 99.5% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is 25 to 48 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during HSDB 8173 therapy.
Alternate Drugs
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Nivolumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Ipilimumab(Unsafe)
Bleomycin(Dangerous)
Cetuximab(Unsafe)
Etoposide(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Dacarbazine(Dangerous)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Docetaxel(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Rituximab(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)